Biohaven Ltd. (BHVN)
NYSE: BHVN · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2022
Who owns Biohaven Ltd.
As filed with the SECHolders of 5% or more
3
Suvretta Capital Management, LLC holds 7.8% of Common Shares, no par value, as its SCHEDULE 13G/A filed Feb 13, 2026 says.
Directors and officers
14
report now, of 14 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Suvretta Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Shares, no par value
JANUS HENDERSON GROUP Ltd.
SCHEDULE 13G/A · filed Jul 8, 2026 · Common Shares · 11.7% in May 15, 2026
Woodline Partners LP
SCHEDULE 13G · filed Aug 14, 2026 · Common Shares, no par value per share
The Vanguard Group
SCHEDULE 13G/A · filed Oct 30, 2025 · Common Stock · reported falling below 5%
What BHVN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Kleo Pharmaceuticals Inc
A company bought · acquisition · Jan 2021 · owns, named in the 10-K filed Mar 2, 2026
14 subsidiaries in 8 countries, from the list filed with the 10-K filed Mar 2, 2026.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$33.1Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Coric Vlad | Chief Executive Officer | 0 | $0 | 0 | 2 | $5.0M |
| Clark George C. | VP, Chief Accounting Officer | 0 | $0 | 0 | 1 | $100,000 |
| Bailey Gregory | director | 0 | $0 | 0 | 1 | $3.0M |
| Childs John W | director | 0 | $0 | 0 | 1 | $25.0M |